We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COCO icon
2076
Vita Coco
COCO
$3.77B
$18.5K ﹤0.01%
+1,891
New +$20K
VTYX
2077
DELISTED
Ventyx Biosciences
VTYX
$18.5K ﹤0.01%
+1,512
New +$22.6K
MLR icon
2078
Miller Industries
MLR
$640M
$18.5K ﹤0.01%
815
RSI icon
2079
Rush Street Interactive
RSI
$2.85B
$18.5K ﹤0.01%
3,956
VRDN icon
2080
Viridian Therapeutics
VRDN
$2.49B
$18.4K ﹤0.01%
+1,592
New +$21.4K
ASLE icon
2081
AerSale
ASLE
$273M
$18.4K ﹤0.01%
1,269
CENN icon
2082
Cenntro
CENN
$8.41M
$18.4K ﹤0.01%
+20
New +$21.2K
FREE
2083
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$18.4K ﹤0.01%
2,962
PWP icon
2084
Perella Weinberg Partners
PWP
$1.33B
$18.3K ﹤0.01%
+3,141
New +$22.7K
VXRT
2085
DELISTED
Vaxart
VXRT
$18.3K ﹤0.01%
5,219
-2,995
-36% -$11.2K
ALNT icon
2086
Allient
ALNT
$1.86B
$18.2K ﹤0.01%
795
AURA icon
2087
Aura Biosciences
AURA
$791M
$18.1K ﹤0.01%
+1,280
New +$21.2K
METC icon
2088
Ramaco Resources Class A
METC
$667M
$18.1K ﹤0.01%
+1,424
New +$21.4K
TARS icon
2089
Tarsus Pharmaceuticals
TARS
$3.02B
$18.1K ﹤0.01%
+1,239
New +$18.6K
GRPN icon
2090
Groupon
GRPN
$894M
$18.1K ﹤0.01%
1,598
ORRF icon
2091
Orrstown Financial Services
ORRF
$855M
$18K ﹤0.01%
743
UVE icon
2092
Universal Insurance Holdings
UVE
$1.18B
$18K ﹤0.01%
1,378
KNSA icon
2093
Kiniksa Pharmaceuticals
KNSA
$6.07B
$17.9K ﹤0.01%
1,846
FFAI
2094
Faraday Future Intelligent Electric
FFAI
$12M
0
NPKI
2095
NPK International
NPKI
$1.18B
$17.9K ﹤0.01%
5,785
CINC
2096
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$17.9K ﹤0.01%
948
AMPS
2097
DELISTED
Altus Power
AMPS
$17.8K ﹤0.01%
+2,823
New +$18.9K
DYN icon
2098
Dyne Therapeutics
DYN
$4.85B
$17.7K ﹤0.01%
2,582
HBCP icon
2099
Home Bancorp
HBCP
$569M
$17.7K ﹤0.01%
518
MVBF icon
2100
MVB Financial
MVBF
$397M
$17.6K ﹤0.01%
567

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.